Why the study?
LVEF and ESV are limited to global systolic function and fail to capture regional functional and anatomical abnormalities, hindering post-AMI risk stratification.
Does automated 3D imaging of end-systolic shape and contraction improve the prediction of 12-month MACE compared to standard LVEF and ESV in AMI survivors?
Does automated 3D imaging of end-systolic shape and contraction improve the prediction of 12-month MACE compared to standard LVEF and ESV in AMI survivors?
Automated 3D left ventricular shape and contraction analysis from CMR significantly improves 12-month MACE prediction in post-AMI patients compared to standard LVEF and ESV.
Novel 3D ES descriptors may refine post-AMI risk stratification beyond LVEF/ESV; leaves open prospective validation before clinical adoption.
BACKGROUND: Left ventricular ejection fraction (LVEF) and end-systolic volume (ESV) remain the main imaging biomarkers for post-acute myocardial infarction (AMI) risk stratification. However, they are limited to global systolic function and fail to capture functional and anatomical regional abnormalities, hindering their performance in risk stratification. OBJECTIVES: This study aimed to identify novel 3-dimensional (3D) imaging end-systolic (ES) shape and contraction descriptors toward risk-related features and superior prognosis in AMI. METHODS: A multicenter cohort of AMI survivors (n = 1,021; median age 63 years; 74.5% male) who underwent cardiac magnetic resonance (CMR) at a median of 3 days after infarction were considered for this study. The clinical endpoint was the 12-month rate of major adverse cardiac events (MACE; n = 73), consisting of all-cause death, reinfarction, and new congestive heart failure. A fully automated pipeline was developed to segment CMR images, build 3D statistical models of shape and contraction in AMI, and find the 3D patterns related to MACE occurrence. RESULTS: The novel ES shape markers proved to be superior to ESV (median cross-validated area under the receiver-operating characteristic curve 0.681 [IQR: 0.679-0.684] vs 0.600 [IQR: 0.598-0.602]; P < 0.001); and 3D contraction to LVEF (0.716 [IQR: 0.714-0.718] vs 0.681 [IQR: 0.679-0.684]; P < 0.001) in MACE occurrence prediction. They also contributed to a significant improvement in a multivariable setting including CMR markers, cardiovascular risk factors, and basic patient characteristics (0.747 [IQR: 0.745-0.749]; P < 0.001). Based on these novel 3D descriptors, 3 impairments caused by AMI were identified: global, anterior, and basal, the latter being the most complementary signature to already known predictors. CONCLUSIONS: The quantification of 3D differences in ES shape and contraction, enabled by a fully automated pipeline, improves post-AMI risk prediction and identifies shape and contraction patterns related to MACE occurrence.
No takes yet. Share an insight, caveat, or question.
Acero et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: